Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...

Merck’s search for its next blockbuster product continues to go beyond cancer. The pharmaceutical giant has agreed to pay $10.8 billion to acquire Prometheus Biosciences, a biotech with a Phase ...

Keytruda sales totaled $5,795 million in Q1 2023, up 17% year-on-year, thanks partly to an increase in its indications for use. At the same time, Robert Davis does not actively use the share buyback ...

Merck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.’s top-selling products. The Food and Drug Administration on Monday ...

Merck stock surges 30% on strong fundamentals, regulatory catalysts, and attractive valuation. See why I rate the MRK stock a ...

AstraZeneca AZN and Merck MRK are both major global pharmaceutical companies with diversified drug portfolios. While Merck is a U.S.-based company, AstraZeneca’s headquarters are in Cambridge, UK.

NEW YORK, Dec 11 (Reuters) - Merck & Co said on Tuesday it plans to begin late-stage trials next year on a drug to raise "good" HDL cholesterol that has not been dogged by the problems that sank a ...

The U.S. now only recommends one dose of an HPV vaccine. It used to say all children should get two to three doses of the ...

Top Delaware court says Bayer not responsible for claims over products sold before 2014 deal Ruling upholds lower court decision In a unanimous ruling, opens new tab signed by Justice Karen Valihura, ...